Case report: EGFR-TKI rechallenge after osimertinib-induced interstitial lung disease: a case report and literature review - Gu, Xiaofei; Zhong, Yonghong; Huang, Huaqiong (Frontiers in pharmacology, 2024)
Keywords: epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI); interstitial lung disease (ILD); non-small cell lung cancer (NSCLC); osimertinib; Pharmacology; rechallenge; epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI); interstitial lung disease (ILD); rechallenge; non-small cell lung cancer (NSCLC); osimertinib